Standard BioTools has a very small Wall Street following as can be seen above. On average, they expect the company to lose $0 ...

Becton Dickinson (BDX) just doubled down on immune system science by teaming up with the University of Pennsylvania’s Institute for Immunology and Immune Health to build advanced flow cytometry panels ...

Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to ...

CXCL12 and CXCL13 are potential biomarkers for RSV bronchiolitis severity and recurrence risk, with elevated levels ...

Gold nanoparticles that cluster in response to T cell enzymes can predict cancer immunotherapy success days before tumors ...

Learn more about whether Charles River Laboratories International, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...

A study published by the International Journal of Molecular Sciences finds that cannabidiol (CBD) may selectively damage ...

Research presented by Dr Erik Sahai has shown that early, reversible diversity in tumour cell state can blunt the effect of ...

Roche researchers have set out how patient-derived organoids, automation and high-content imaging have combined within the ...

IGIB, has launched India's first Centre of Excellence for Single-Cell Multiomics to enhance research in immunity, cancer, and ...

Antigen-driven TCR signaling in the epidermis during CD8+ TRM differentiation results in a lower TGFβ requirement for persistence and increased proliferative capacity that together enhance epidermal ...

The company’s GYN Surgical division posted revenues of $679.8 million in fiscal 2025, a 6% increase over fiscal 2024. Over ...